A study found that a widely deployed AI dermatology diagnostic tool performed well on light-skinned patients but had near-zero accuracy for detecting melanoma in patients with darker skin tones. The model had been trained overwhelmingly on images of light skin, making it effectively useless — and potentially dangerous — for a significant portion of patients. The study triggered FDA scrutiny of AI medical device training data requirements.